Cited by 817Hematopoietic Stem Cell TransplantationPI3K/AKT/mTOR signaling in cancerAcute Myeloid Leukemia Research

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention

Zhang, Jiwang, Grindley, Justin C., Yin, Tong, Jayasinghe, Sachintha, He, Xi C., Ross, Jason T., Haug, Jeffrey S., Rupp, Dawn, Porter-Westpfahl, Kimberly S., Wiedemann, Leanne M., Wu, Hong, Li, Linheng·2006·Nature

DOI 10.1038/nature04747

Open this paper in CoChat — free account

Abstract

Haematopoietic stem cells (HSCs) must achieve a balance between quiescence and activation that fulfils immediate demands for haematopoiesis without compromising long-term stem cell maintenance, yet little is known about the molecular events governing this balance. Phosphatase and tensin homologue (PTEN) functions as a negative regulator of the phosphatidylinositol-3-OH kinase (PI(3)K)-Akt pathway, which has crucial roles in cell proliferation, survival, differentiation and migration. Here we show that inactivation of PTEN in bone marrow HSCs causes their short-term expansion, but long-term decline, primarily owing to an enhanced level of HSC activation. PTEN-deficient HSCs engraft normally in recipient mice, but have an impaired ability to sustain haematopoietic reconstitution, reflecting the dysregulation of their cell cycle and decreased retention in the bone marrow niche. Mice with PTEN-mutant bone marrow also have an increased representation of myeloid and T-lymphoid lineages and develop myeloproliferative disorder (MPD). Notably, the cell populations that expand in PTEN mutants match those that become dominant in the acute myeloid/lymphoid leukaemia that develops in the later stages of MPD. Thus, PTEN has essential roles in restricting the activation of HSCs, in lineage fate determination, and in the prevention of leukaemogenesis.

Integrity signals

Registry

Crossref · 10.1038/nature04747

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Osteoblastic cells regulate the haematopoietic stem cell niche
Calvi, L. M., Adams, G. B., Weibrecht, K. W., Weber, J. M., Olson, D. P., Knight, M. C., Martin, R. P., Schipani, E., Pajevic, P. D., Bringhurst, F. R., et al. (2003) · Nature · doi:10.1038/nature02040 · Cited by 3,559
SLAM Family Receptors Distinguish Hematopoietic Stem and Progenitor Cells and Reveal Endothelial Niches for Stem Cells
Kiel, M. J., Yilmaz, Ö. H., Iwashita, T., Yilmaz, O. H., Terhorst, C., & Morrison, S. J. (2005) · Cell · doi:10.1016/j.cell.2005.05.026 · Cited by 3,168
Identification of the haematopoietic stem cell niche and control of the niche size
Zhang, J., Niu, C. S., Ye, L., Huang, H., He, X. C., Tong, W.-G., Ross, J., Haug, J., Johnson, T. J., Feng, J. Q., et al. (2003) · Nature · doi:10.1038/nature02041 · Cited by 2,948
Self-citation
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
Akashi, K., Traver, D., Miyamoto, T., & Weissman, I. L. (2000) · Nature · doi:10.1038/35004599 · Cited by 2,617
Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
Kondo, M., Weissman, I. L., & Akashi, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80453-5 · Cited by 2,253
Tie2/Angiopoietin-1 Signaling Regulates Hematopoietic Stem Cell Quiescence in the Bone Marrow Niche
Arai, F., Hirao, A., Ohmura, M., Sato, H., Matsuoka, S., Takubo, K., Ito, K., Koh, G. Y., & Suda, T. (2004) · Cell · doi:10.1016/j.cell.2004.07.004 · Cited by 1,958
Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand
Heissig, B., Hattori, K., Dias, S., Friedrich, M., Ferris, B., Hackett, N. R., Crystal, R. G., Besmer, P., Lyden, D. C., Moore, M. A. S., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00754-7 · Cited by 1,744
Inducible Gene Targeting in Mice
Kühn, R., Schwenk, F., Aguet, M., & Rajewsky, K. (1995) · Science · doi:10.1126/science.7660125 · Cited by 1,641
Hematopoietic Stem Cell Quiescence Maintained by p21 cip1/waf1
Cheng, T., Rodrigues, N., Shen, H., Yang, Y.-G., Dombkowski, D., Sykes, M., & Scadden, D. T. (2000) · Science · doi:10.1126/science.287.5459.1804 · Cited by 1,339
Identification of Flt3+ Lympho-Myeloid Stem Cells Lacking Erythro-Megakaryocytic Potential
Adolfsson, J., Månsson, R., Buza-Vidas, N., Hultquist, A., Liuba, K., Jensen, C. T., Bryder, D., Yang, L., Borge, O. J., Thorén, L., et al. (2005) · Cell · doi:10.1016/j.cell.2005.02.013 · Cited by 1,323

Flagged first, then by citations

Show all 30 references

Sorted by citations

Items 101–200 of 814

Maintenance of hematopoietic stem cells through regulation of Wnt and mTOR pathways
Huang, J. Y., Nguyen-McCarty, M., Hexner, E. O., Danet-Desnoyers, G. A., & Klein, P. S. (2012) · Nature Medicine · doi:10.1038/nm.2984 · Cited by 221
Selective targeting of radiation-resistant tumor-initiating cells
Zhang, M., Atkinson, R. L., & Rosen, J. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910179107 · Cited by 223
ETV6 mutations in early immature human T cell leukemias
Vlierberghe, P. V., Ambesi‐Impiombato, A., Pérez-García, A., Haydu, J. E., Rigo, I., Hadler, M., Tosello, V., Gatta, G. D., Paietta, E. M., Racevskis, J., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20112239 · Cited by 214
mTORC1-dependent and -independent regulation of stem cell renewal, differentiation, and mobilization
Gan, B., Sahin, E., Jiang, S., Sánchez‐Aguilera, A., Scott, K. L., Chin, L., Williams, D. A., Kwiatkowski, D. J., & DePinho, R. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810584105 · Cited by 204
The Dlk1-Gtl2 Locus Preserves LT-HSC Function by Inhibiting the PI3K-mTOR Pathway to Restrict Mitochondrial Metabolism
Qian, P., He, X., Paulson, A., Li, Z., Fang, T., Perry, J. M., Guo, F., Zhao, M. L., Zhi, L., Venkatraman, A., et al. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.11.001 · Cited by 203
Self-citation
mTOR Complex 1 Plays Critical Roles in Hematopoiesis and Pten-Loss-Evoked Leukemogenesis
Kalaitzidis, D., Sykes, S. M., Wang, Z., Punt, N., Tang, Y., Ragu, C., Sinha, A. U., Lane, S., Souza, A. L., Clish, C. B., et al. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.06.009 · Cited by 199
Less Is More: Unveiling the Functional Core of Hematopoietic Stem Cells through Knockout Mice
Rossi, L., Lin, K. K., Boles, N. C., Yang, L., King, K. Y., Jeong, M., Mayle, A., & Goodell, M. A. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.08.006 · Cited by 205
Targeting breast cancer stem cells
McDermott, S., & Wicha, M. S. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.06.005 · Cited by 198
PTEN Tumor-Suppressor: The Dam of Stemness in Cancer
Luongo, F., Colonna, F., Calapà, F., Vitale, S., Fiori, M. E., & Maria, R. D. (2019) · Cancers · doi:10.3390/cancers11081076 · Cited by 200
Targeting the leukemic stem cell: the Holy Grail of leukemia therapy
Misaghian, N., Ligresti, G., Steelman, L. S., Bertrand, F. E., Bäsecke, J., Libra, M., Nicoletti, F., Stivala, F., Milella, M., Tafuri, A., et al. (2008) · Leukemia · doi:10.1038/leu.2008.246 · Cited by 191
Cooperation between both Wnt/β-catenin and PTEN/PI3K/Akt signaling promotes primitive hematopoietic stem cell self-renewal and expansionPreprint
Perry, J. M., He, X., Sugimura, R., Grindley, J. C., Haug, J. S., Ding, S., & Li, L. (2011) · Genes & Development · doi:10.1101/gad.17421911 · Cited by 191
Self-citation
mTOR Activation Induces Tumor Suppressors that Inhibit Leukemogenesis and Deplete Hematopoietic Stem Cells after Pten Deletion
Lee, J., Nakada, D., Yilmaz, Ö. H., Tóthová, Z., Joseph, N. M., Lim, M. S., Gilliland, D. G., & Morrison, S. J. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.09.015 · Cited by 189
Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALLPreprint
Matsuoka, S., Oike, Y., Onoyama, I., Iwama, A., Arai, F., Takubo, K., Mashimo, Y., Oguro, H., Nitta, E., Ito, K., et al. (2008) · Genes & Development · doi:10.1101/gad.1621808 · Cited by 192
Temporal Changes in PTEN and mTORC2 Regulation of Hematopoietic Stem Cell Self-Renewal and Leukemia Suppression
Magee, J. A., Ikenoue, T., Nakada, D., Lee, J., Guan, K., & Morrison, S. J. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.05.026 · Cited by 188
Reactive Oxygen Species and Mitochondrial Homeostasis as Regulators of Stem Cell Fate and Function
Tan, D. Q., & Suda, T. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7273 · Cited by 183
Darwinian medicine: a case for cancer
Greaves, M. F. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2071 · Cited by 182
The role of the chromatin remodeler Mi-2β in hematopoietic stem cell self-renewal and multilineage differentiationPreprint
Yoshida, T., Hazan, I., Zhang, J., Ng, S. Y., Naito, T., Snippert, H. J. G., Heller, E. J., Qi, X., Lawton, L. N., Williams, C. J., et al. (2008) · Genes & Development · doi:10.1101/gad.1642808 · Cited by 184
Self-citation
Human papillomaviruses, cervical cancer and cell polarity
Thomas, M., Narayan, N., Pim, D. C., Tomaić, V., Massimi, P., Nagasaka, K., Kranjec, C., Gammoh, N., & Banks, L. (2008) · Oncogene · doi:10.1038/onc.2008.351 · Cited by 186
Hematopoietic Stem Cell Quiescence Is Maintained by Compound Contributions of the Retinoblastoma Gene Family
Viatour, P., Somervaille, T. C., Venkatasubrahmanyam, S., Kogan, S., McLaughlin, M. E., Weissman, I. L., Butte, A. J., Passegué, E., & Sage, J. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.07.009 · Cited by 178
Mammalian Target of Rapamycin Controls Dendritic Cell Development Downstream of Flt3 Ligand Signaling
Sathaliyawala, T., O’Gorman, W. E., Greter, M., Bogunovic, M., Konjufca, V. H., Hou, Z. E., Nolan, G. P., Miller, M. J., Mérad, M., & Reizis, B. (2010) · Immunity · doi:10.1016/j.immuni.2010.09.012 · Cited by 187
Chromatin Regulatory Mechanisms in Pluripotency
Lessard, J. A., & Crabtree, G. R. (2010) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-051809-102012 · Cited by 185
Oxidative Stress Regulation of Stem and Progenitor Cells
Pervaiz, S., Taneja, R., & Ghaffari, S. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2804 · Cited by 176
Cancer Stem Cell–Directed Therapies: Recent Data From the Laboratory and Clinic
Park, C. Y., Tseng, D., & Weissman, I. L. (2008) · Molecular Therapy · doi:10.1038/mt.2008.254 · Cited by 179
Targeting the mTOR kinase domain: the second generation of mTOR inhibitors
Zhang, Y.-J., Duan, Y.-W., & Zheng, X.-F. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.02.008 · Cited by 176
Pten Deletion in Adult Hippocampal Neural Stem/Progenitor Cells Causes Cellular Abnormalities and Alters Neurogenesis
Amiri, A., Cho, W., Zhou, J., Birnbaum, S. G., Sinton, C. M., McKay, R. M., & Parada, L. F. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5462-11.2012 · Cited by 175
Tumor Heterogeneity: Mechanisms and Bases for a Reliable Application of Molecular Marker Design
Díaz‐Cano, S. J. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13021951 · Cited by 179
Stem Cell Factor SALL4 Represses the Transcriptions of PTEN and SALL1 through an Epigenetic Repressor Complex
Lu, J., Jeong, H., Kong, N., Yang, Y., Carroll, J., Luo, H. R., Silberstein, L. E., YupoMa, & Chai, L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005577 · Cited by 168
“PTEN is a tumor suppressor gene and essential for both normal hematopoiesis and leukemogenesis [28–30].”
Noncanonical Wnt signaling in vertebrate development, stem cells, and diseases
Sugimura, R., & Li, L. (2010) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.20195 · Cited by 174
Self-citation
p53 loss promotes acute myeloid leukemia by enabling aberrant self-renewalPreprint
Zhao, Z., Zuber, J. A., Díaz-Flores, E., Lintault, L., Kogan, S. C., Shannon, K., & Lowe, S. W. (2010) · Genes & Development · doi:10.1101/gad.1940710 · Cited by 175
Activity of the Novel Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235 against T-Cell Acute Lymphoblastic Leukemia
Chiarini, F., Grimaldi, C., Ricci, F., Tazzari, P. L., Evangelisti, C., Ognibene, A., Battistelli, M., Falcieri, E., Melchionda, F., Pession, A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1814 · Cited by 167
Regulation of FOXO Factors in Mammalian Cells
Brown, A. K., & Webb, A. E. (2017) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2017.10.006 · Cited by 177
Normal stem cells and cancer stem cells: similar and different
Shackleton, M. J. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.04.002 · Cited by 168
Genetic alterations of PTEN in human melanoma
Aguissa-Touré, A.-H., & Li, G. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0878-0 · Cited by 170
Arsenic Exposure Transforms Human Epithelial Stem/Progenitor Cells into a Cancer Stem-like Phenotype
Tokar, E. J., Diwan, B. A., & Waalkes, M. P. (2009) · Environmental Health Perspectives · doi:10.1289/ehp.0901059 · Cited by 163
Modelling mammalian cellular quiescence
Yao, G. (2014) · Interface Focus · doi:10.1098/rsfs.2013.0074 · Cited by 180
Judicious Toggling of mTOR Activity to Combat Insulin Resistance and Cancer: Current Evidence and Perspectives
Ong, P. S., Wang, L. Z., Dai, X., Tseng, S. H., Loo, S. J., & Sethi, G. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00395 · Cited by 162
Reactive oxygen species (ROS) in cancer pathogenesis and therapy: An update on the role of ROS in anticancer action of benzophenanthridine alkaloids
Khan, A. Q., Rashid, K., AlAmodi, A. A., Agha, M. V., Akhtar, S., Hakeem, I., Raza, S. S., & Shahab Uddin, M. S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112142 · Cited by 164
Sustained PU.1 Levels Balance Cell-Cycle Regulators to Prevent Exhaustion of Adult Hematopoietic Stem Cells
Staber, P. B., Zhang, P., Ye, M., Welner, R. S., Nombela-Arrieta, C., Bach, C., Kerenyi, M., Bartholdy, B. A., Zhang, H., Alberich-Jordà, M., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.007 · Cited by 158
Self-citation
PTEN nuclear localization is regulated by oxidative stress and mediates p53-dependent tumor suppression
Chang, C.-J., Mulholland, D. J., Valamehr, B., Mosessian, S., Sellers, W. R., & Wu, H. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00310-08 · Cited by 155
Self-citation
MicroRNA-486 regulates normal erythropoiesis and enhances growth and modulates drug response in CML progenitors
Wang, L., Li, L., Li, L., Chu, S., Shiang, K.-D., Li, M., Sun, H., Xu, J., Xiao, F., Sun, G., et al. (2014) · Blood · doi:10.1182/blood-2014-06-581926 · Cited by 153
Self-citation
Dietary and Metabolic Control of Stem Cell Function in Physiology and Cancer
Mihaylova, M. M., Sabatini, D. M., & Yilmaz, Ö. H. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.02.008 · Cited by 158
The ATM–BID pathway regulates quiescence and survival of haematopoietic stem cells
Maryanovich, M., Oberkovitz, G., Niv, H., Vorobiyov, L., Zaltsman, Y., Brenner, O. J., Lapidot, T., Jung, S., & Gross, A. (2012) · Nature Cell Biology · doi:10.1038/ncb2468 · Cited by 159
Ribosomal DNA copy number loss and sequence variation in cancer
Xu, B., Li, H., Perry, J. M., Singh, V. P., Unruh, J. R., Yu, Z., Zakari, M., McDowell, W., Li, L., & Gerton, J. L. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006771 · Cited by 158
Self-citation
PTEN in DNA damage repair
Ming, M., & He, Y. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.01.003 · Cited by 147
Deregulation of Signaling Pathways in Acute Myeloid Leukemia
Scholl, C., Gilliland, D. G., & Fröhling, S. (2008) · Seminars in Oncology · doi:10.1053/j.seminoncol.2008.04.004 · Cited by 149
Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins
Yoshimi, A., Goyama, S., Watanabe‐Okochi, N., Yoshiki, Y., Nannya, Y., Nitta, E., Arai, S., Sato, T., Shimabe, M., Nakagawa, M. M., et al. (2011) · Blood · doi:10.1182/blood-2009-12-261602 · Cited by 146
ROS‐mediated amplification of AKT/mTOR signalling pathway leads to myeloproliferative syndrome in Foxo3−/− mice
Yalcin, S., Marinković, D., Mungamuri, S. K., Zhang, X., Tong, W., Sellers, R. S., & Ghaffari, S. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.292 · Cited by 150
mTOR Cross-Talk in Cancer and Potential for Combination Therapy
Conciatori, F., Ciuffreda, L., Bazzichetto, C., Falcone, I., Pilotto, S., Bria, E., Cognetti, F., & Milella, M. (2018) · Cancers · doi:10.3390/cancers10010023 · Cited by 145
PTEN, Stem Cells, and Cancer Stem Cells
Hill, R., & Wu, H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r800071200 · Cited by 143
Self-citation
Understanding hematopoietic stem-cell microenvironments
Li, Z., & Li, L. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.08.001 · Cited by 145
Self-citation
Synergy against PML-RARa: targeting transcription, proteolysis, differentiation, and self-renewal in acute promyelocytic leukemia
dos Santos, G. A., Kats, L. M., & Pandolfi, P. P. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20131121 · Cited by 147
Akt as a therapeutic target in cancer
Steelman, L. S., Stadelman, K. M., Chappell, W. H., Horn, S., Bäsecke, J., Cervello, M., Nicoletti, F., Libra, M., Stivala, F., Martelli, A. M., et al. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.9.1139 · Cited by 145
Nutrient-sensing pathways and metabolic regulation in stem cells
Ochocki, J. D., & Simon, M. C. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201303110 · Cited by 140
SHIP1 Inhibition Increases Immunoregulatory Capacity and Triggers Apoptosis of Hematopoietic Cancer Cells
Brooks, R., Fuhler, G. M., Iyer, S., Smith, M. J., Park, M.-Y., Paraiso, K. H. T., Engelman, R. W., & Kerr, W. G. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902844 · Cited by 140
G9a/GLP-dependent histone H3K9me2 patterning during human hematopoietic stem cell lineage commitmentPreprint
Chen, X., Skutt-Kakaria, K., Davison, J., Ou, Y.-L., Choi, E., Malik, P., Loeb, K. R., Wood, B. L., Georges, G. E., Torok‐Storb, B., et al. (2012) · Genes & Development · doi:10.1101/gad.200329.112 · Cited by 138
PI3Kδ Inhibitors in Cancer: Rationale and Serendipity Merge in the Clinic
Fruman, D. A., & Rommel, C. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0249 · Cited by 140
Targeting Cardiac Stem Cell Senescence to Treat Cardiac Aging and Disease
Cianflone, E., Torella, M., Biamonte, F., Angelis, A. D., Urbanek, K., Costanzo, F. S., Rota, M., Ellison, G. M., & Torella, D. (2020) · Cells · doi:10.3390/cells9061558 · Cited by 137
Dietary restriction improves repopulation but impairs lymphoid differentiation capacity of hematopoietic stem cells in early aging
Tang, D., Tao, S., Chen, Z., Koliesnik, I. O., Calmes, P. G., Hoerr, V., Han, B., Gebert, N., Zörnig, M., Löffler, B., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151100 · Cited by 133
The emerging role of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in normal myelopoiesis and leukemogenesis
Martelli, A. M., Evangelisti, C., Chiarini, F., Grimaldi, C., Cappellini, A., Ognibene, A., & McCubrey, J. A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.04.005 · Cited by 134
Nanostructured scaffold as a determinant of stem cell fate
Krishna, L., Dhamodaran, K., Jayadev, C., Chatterjee, K., Shetty, R., Khora, S. S., & Das, D. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0440-y · Cited by 134
The PI3K/PKB signaling module as key regulator of hematopoiesis: implications for therapeutic strategies in leukemia
Polak, R., & Buitenhuis, M. (2011) · Blood · doi:10.1182/blood-2011-07-366203 · Cited by 136
Enhanced c-Met activity promotes G-CSF–induced mobilization of hematopoietic progenitor cells via ROS signaling
Tesio, M., Golan, K., Corso, S., Giordano, S., Schajnovitz, A., Vagima, Y., Shivtiel, S., Kalinkovich, A., Caione, L., Gammaitoni, L., et al. (2010) · Blood · doi:10.1182/blood-2009-06-230359 · Cited by 134
Pivotal role for glycogen synthase kinase–3 in hematopoietic stem cell homeostasis in mice
Huang, J. Y., Zhang, Y., Bersenev, A., O’Brien, W. T., Tong, W., Emerson, S. G., & Klein, P. S. (2009) · Journal of Clinical Investigation · doi:10.1172/jci40572 · Cited by 131
The nuclear receptor tailless induces long-term neural stem cell expansion and brain tumor initiationPreprint
Liu, H., Wang, Y., Belz, T., Bock, D., Takacs, A., Radlwimmer, B., Barbus, S., Reifenberger, G., Lichter, P., & Schütz, G. (2010) · Genes & Development · doi:10.1101/gad.560310 · Cited by 131
mTORC1 is essential for leukemia propagation but not stem cell self-renewal
Hoshii, T., Tadokoro, Y., Naka, K., Ooshio, T., Muraguchi, T., Sugiyama, N., Soga, T., Araki, K., Yamamura, K., & Hirao, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62279 · Cited by 140
Knockdown of N-cadherin suppresses the long-term engraftment of hematopoietic stem cells
Hosokawa, K., Arai, F., Yoshihara, H., Iwasaki, H., Nakamura, Y., Gomei, Y., & Suda, T. (2010) · Blood · doi:10.1182/blood-2009-05-224857 · Cited by 129
Surviving change: the metabolic journey of hematopoietic stem cells
Kohli, L., & Passegue, E. A. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.04.001 · Cited by 136
Selective Targeting of Cancer Stem Cells
Körkaya, H., & Wicha, M. S. (2007) · BioDrugs · doi:10.2165/00063030-200721050-00002 · Cited by 126
Regional Localization within the Bone Marrow Influences the Functional Capacity of Human HSCs
Guezguez, B., Campbell, C. J. V., Boyd, A. L., Karanu, F., Casado, F. L., Cresce, C. D., Collins, T. J., Shapovalova, Z., Xenocostas, A., & Bhatia, M. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.06.015 · Cited by 131
Akt-p53-miR-365-cyclin D1/cdc25A axis contributes to gastric tumorigenesis induced by PTEN deficiency
Guo, S., Ye, H., Teng, Y., Wang, Y.-L., Yang, G., Li, X.-B., Zhang, C., Yang, X., Yang, Z., & Yang, X. Y. (2013) · Nature Communications · doi:10.1038/ncomms3544 · Cited by 126
Proteostatic and Metabolic Control of Stemness
García‐Prat, L., Sousa‐Victor, P., & Muñoz‐Cánoves, P. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.04.011 · Cited by 125
Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment
Martelli, A. M., Chiarini, F., Evangelisti, C., Cappellini, A., Buontempo, F., Bressanin, D., Fini, M., & McCubrey, J. A. (2012) · Oncotarget · doi:10.18632/oncotarget.477 · Cited by 122
Pten is necessary for the quiescence and maintenance of adult muscle stem cells
Yue, F., Bi, P., Wang, C., Shan, T., Nie, Y., Ratliff, T. L., Gavin, T. P., & Kuang, S. (2017) · Nature Communications · doi:10.1038/ncomms14328 · Cited by 125
Targeting the PI3K/AKT/mTOR signaling network in acute myelogenous leukemia
Martelli, A. M., Evangelisti, C., Chiarini, F., Grimaldi, C., Manzoli, L., & McCubrey, J. A. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/14728220903136775 · Cited by 123
Pten and p53 Converge on c-Myc to Control Differentiation, Self-renewal, and Transformation of Normal and Neoplastic Stem Cells in GlioblastomaPreprint
Zheng, H., Ying, H., Yan, H., Kimmelman, A. C., Hiller, D. J., Chen, A.-J., Perry, S. R., Tonon, G., Chu, G. C., Ding, Z., et al. (2008) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2008.73.047 · Cited by 122
Tumor suppressor PTEN is a physiologic suppressor of chemoattractant-mediated neutrophil functions
Subramanian, K. K., Jia, Y., Zhu, D., Simms, B. T., Jo, H., Hattori, H., You, J., Mizgerd, J. P., & Luo, H. R. (2007) · Blood · doi:10.1182/blood-2006-10-055319 · Cited by 118
Therapeutic targeting of the mTOR ‐signalling pathway in cancer: benefits and limitations
Moschetta, M., Reale, A., Marasco, C., Vacca, A., & Carratù, M. R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12749 · Cited by 119
Myeloid Cell-Derived Reactive Oxygen Species Externally Regulate the Proliferation of Myeloid Progenitors in Emergency Granulopoiesis
Kwak, H. J., Liu, P., Bajrami, B., Xu, Y., Park, S., Nombela‐Arrieta, C., Mondal, S., Sun, Y., Zhu, H., Chai, L., et al. (2015) · Immunity · doi:10.1016/j.immuni.2014.12.017 · Cited by 118
PTEN is a tumor suppressor in CML stem cells and BCR-ABL–induced leukemias in mice
Peng, C., Chen, Y., Yang, Z., Zhang, H., Osterby, L., Rosmarin, A. G., & Li, S. (2009) · Blood · doi:10.1182/blood-2009-06-228130 · Cited by 117
Acute Promyelocytic Leukemia: Update on the Mechanisms of Leukemogenesis, Resistance and on Innovative Treatment Strategies
Noguera, N. I., Catalano, G., Banella, C., Divona, M., Faraoni, I., Ottone, T., Arcese, W. G., & Voso, M. T. (2019) · Cancers · doi:10.3390/cancers11101591 · Cited by 118
Megakaryopoiesis
Geddis, A. E. (2010) · Seminars in Hematology · doi:10.1053/j.seminhematol.2010.03.001 · Cited by 115
The Evolution of Lifespan and Age-Dependent Cancer Risk
Rozhok, A. I., & DeGregori, J. V. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.09.004 · Cited by 117
Molecular signaling of the epithelial to mesenchymal transition in generating and maintaining cancer stem cells
Ouyang, G., Wang, Z., Fang, X., Liu, J., & Yang, C. J. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0338-2 · Cited by 115
ATG7 regulates energy metabolism, differentiation and survival of Philadelphia-chromosome-positive cells
Karvela, M., Baquero, P., Kuntz, E. M., Mukhopadhyay, A., Mitchell, R., Allan, E. K., Chan, E. Y. W., Kranc, K. R., Calabretta, B., Salomoni, P., et al. (2016) · Autophagy · doi:10.1080/15548627.2016.1162359 · Cited by 114
Non–lineage/stage-restricted effects of a gain-of-function mutation in tyrosine phosphatase Ptpn11 (Shp2) on malignant transformation of hematopoietic cells
Xu, D., Liu, X., Yu, W., Meyerson, H. J., Guo, C., Gerson, S. L., & Qu, C. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20110450 · Cited by 115
Cancer stem cells and “stemness” genes in neuro-oncology
Nicolis, S. K. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.08.022 · Cited by 113
Mechanisms controlling hematopoietic stem cell functions during normal hematopoiesis and hematological malignancies
Warr, M. R., Pietras, E. M., & Passegué, E. (2011) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.145 · Cited by 112
TBK1 Regulates Prostate Cancer Dormancy through mTOR Inhibition
Kim, J. K., Jung, Y., Wang, J., Joseph, J., Mishra, A., Hill, E. E., Krebsbach, P. H., Pienta, K. J., Shiozawa, Y., & Taichman, R. S. (2013) · Neoplasia · doi:10.1593/neo.13402 · Cited by 113
Rapamycin Suppresses Self-Renewal and Vasculogenic Potential of Stem Cells Isolated from Infantile Hemangioma
Greenberger, S., Yuan, S., Walsh, L. A., Boscolo, E., Kang, K.-T., Matthews, B., Mulliken, J. B., & Bischoff, J. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.300 · Cited by 94
Dual role for Insulin/TOR signaling in the control of hematopoietic progenitor maintenance in Drosophila
Benmimoun, B., Polesello, C., Waltzer, L., & Haenlin, M. (2012) · Development · doi:10.1242/dev.080259 · Cited by 111
The roles of PTEN in development, physiology and tumorigenesis in mouse models: a tissue-by-tissue survey
Knobbe-Thomsen, C. B., Lapin, V., Suzuki, A., & Mak, T. W. (2008) · Oncogene · doi:10.1038/onc.2008.238 · Cited by 110
Novel biological insights in T-cell acute lymphoblastic leukemia
Durinck, K., Goossens, S., Peirs, S., Wallaert, A., Loocke, W. V., Matthijssens, F., Pieters, T., Milani, G., Lammens, T., Rondou, P., et al. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.05.017 · Cited by 111
mTORC1 Activation during Repeated Regeneration Impairs Somatic Stem Cell Maintenance
Haller, S., Kapuria, S., Riley, R. R., O’Leary, M. N., Schreiber, K. H., Andersen, J. K., Melov, S., Que, J., Rando, T. A., Rock, J. R., et al. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.11.008 · Cited by 120
PR-domain–containing Mds1-Evi1 is critical for long-term hematopoietic stem cell function
Zhang, Y., Stehling-Sun, S., Lezon-Geyda, K., Juneja, S. C., Coillard, L., Chatterjee, G., Wuertzer, C. A., Camargo, F. D., & Perkins, A. S. (2011) · Blood · doi:10.1182/blood-2011-02-334680 · Cited by 108
Beyond transcription factors: how oncogenic signalling reshapes the epigenetic landscape
Liu, F., Wang, L., Perna, F., & Nimer, S. D. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.41 · Cited by 109
Inactivation of Pten in Osteo-Chondroprogenitor Cells Leads to Epiphyseal Growth Plate Abnormalities and Skeletal Overgrowth
Ford-Hutchinson, A. F., Ali, Z., Lines, S. E., Hallgrímsson, B., Boyd, S. K., & Jirik, F. R. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070420 · Cited by 113
MT1-MMP and RECK are involved in human CD34+ progenitor cell retention, egress, and mobilization
Vagima, Y., Avigdor, A., Goichberg, P., Shivtiel, S., Tesio, M., Kalinkovich, A., Golan, K., Dar, A., Kollet, Ó., Petit, I., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36541 · Cited by 110
Fancd2 −/− mice have hematopoietic defects that can be partially corrected by resveratrol
Zhang, Q., Loza, L. I. M., Eaton, L., Duncan, A. W., Goldman, D. C., Anur, P., Watanabe‐Smith, K., Rathbun, R. K., Fleming, W., Bagby, G. C., et al. (2010) · Blood · doi:10.1182/blood-2010-04-278226 · Cited by 109
Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients
Santamaría, C., Muntión, S., Rosón, B., Blanco, B., López‐Villar, O., Carrancio, S., Sanchez-Guijo, F. M., Díez‐Campelo, M., Álvarez-Fernández, S., Sarasquete, M. E., et al. (2012) · Haematologica · doi:10.3324/haematol.2011.054437 · Cited by 109
The PKB/FOXO switch in aging and cancer
Kloet, D. E. A., & Burgering, B. M. T. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.04.003 · Cited by 106

Authors: Zhang, J., Grindley, J. C., Yin, T., Jayasinghe, S., He, X. C., Ross, J. T., Haug, J. S., Rupp, D., Porter-Westpfahl, K. S., Wiedemann, L. M., Wu, H., & Li, L.
Affiliations: Stowers Institute for Medical Research (US)
University of California, Los Angeles (US)
Corresponding author: Li, Linheng
ORCID: Zhang, Jiwang
Yin, Tong
Jayasinghe, Sachintha
He, Xi C.
Haug, Jeffrey S.
Wiedemann, Leanne M.
Wu, Hong
Li, Linheng
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2006-04-23
Volume: 441
Issue: 7092
Pages: 518-522
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature04747
OpenAlex: W2057403210
Cited by: 817
References: 30
Citations by year: 2026: 7 · 2025: 6 · 2024: 9 · 2023: 19 · 2022: 18 · 2021: 30 · 2020: 22 · 2019: 29 · 2018: 24 · 2017: 29 · 2016: 48 · 2015: 40 · 2014: 58 · 2013: 61 · 2012: 55
FWCI: 43.78
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Topics: Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
Keywords: PTEN, hematopoietic stem cells, leukemia stem cells, PI3K/Akt signaling, stem cell self-renewal, HSC quiescence, lineage choice, myeloproliferative neoplasms, acute myeloid leukemia, acute lymphoblastic leukemia, rapamycin, bone marrow microenvironment, haematopoietic reconstitution
MeSH terms: Animals, Cell Count, Cell Cycle, Hematopoietic Stem Cells, Leukemia, Mutation, Gene Expression, Cell Lineage, Cyclin D1, Cell Proliferation, PTEN Phosphohydrolase, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks